Q1 2025 revenue declined 1.3% year-over-year to KRW 107.1 billion, with a small operating loss but improved margins. The company is investing in capacity and R&D, while facing cyclical demand and regulatory risks. Major capital was raised for facility expansion and a key subsidiary completed its IPO.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.